US Patent Issued to Washington University, The Scripps Research Institute, Icahn School of Medicine at Mt. Sinai on Dec. 30 for "Pan-neuraminidase inhibiting antibodies" (New York, Missouri, California Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,503, issued on Dec. 30, was assigned to Washington University (St. Louis), The Scripps Research Institute (La Jolla, Calif.) and Icahn School of Medicine at Mt. Sinai (New York).

"Pan-neuraminidase inhibiting antibodies" was invented by Ali Ellebedy (St. Louis), Florian Krammer (New York) and Ian Wilson (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies against influenza neuraminidase, compositions containing the antibodies and methods of using the antibodies."

The patent was filed on May 29, 2020, under Application No. 17/615,309.

*For further information, including images, charts and tabl...